SANUWAVE Health Reports Record Q4 & Full-Year 2025 Revenue, Returns to Profitability, and Issues Strong 2026 Guidance
SNWV is trading near its 52-week low of $18.61 (0.5% above the low) on elevated volume (2.7× avg).
Summary
SANUWAVE Health announced record revenues for Q4 and full-year 2025, a significant turnaround to net income, and provided robust revenue guidance for 2026, following a prior non-reliance notice on financial statements.
Key Events · Earnings and Guidance · SNWV
-
Record Revenue Achieved
Reported record Q4 2025 revenue of $13.4 million (up 29.7%) and record full-year 2025 revenue of $44.1 million (up 35%).
-
Return to Profitability
Swung from a net loss of $33.1 million in 2024 to a net income of $11.8 million in 2025, driven by operating profit and changes in derivative liabilities.
-
Strong Adjusted EBITDA Growth
Adjusted EBITDA for the full year 2025 increased significantly to $13.6 million, up from $7.2 million in 2024.
-
Positive 2026 Revenue Guidance
Forecasts Q1 2026 revenue of $9.6-$10.3 million and initiates full-year 2026 revenue guidance of $51.0-$55.0 million, representing 16-25% growth.
Analysis · SNWV · Industrial Applications And Services
This 8-K filing is highly important as it addresses the prior non-reliance notice from March 13, 2026, by providing restated and strong financial results for Q4 and the full year 2025. The company achieved record quarterly and annual revenues, with full-year revenue increasing 35% to $44.1 million. Critically, SANUWAVE Health swung from a substantial net loss in 2024 to a net income of $11.8 million in 2025, alongside a near doubling of Adjusted EBITDA. The positive momentum is expected to continue with strong revenue guidance for 2026, projecting 16-25% growth. This comprehensive positive financial update, especially while the stock is trading near its 52-week low, could significantly boost investor confidence and re-establish financial transparency after recent accounting concerns.
How filings like this one have moved
In the 30 days to Oct 3, 2026, 36.5% of the 1062 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.61%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SNWV was trading at $18.70 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $161.7M. The 52-week trading range was $18.61 to $46.59. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.